Sarah Bligh, MD | |
705 N Sioux Point Rd Ste 100, Dakota Dunes, SD 57049-5091 | |
(605) 217-5500 | |
(605) 217-5515 |
Full Name | Sarah Bligh |
---|---|
Gender | Female |
Speciality | Gastroenterology |
Experience | 15 Years |
Location | 705 N Sioux Point Rd Ste 100, Dakota Dunes, South Dakota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225266364 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 42647 (Iowa) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Dunes Surgical Hospital | Dakota dunes, SD | Hospital |
St Lukes Regional Medical Center | Sioux city, IA | Hospital |
Mercyone Siouxland | Sioux city, IA | Hospital |
Burgess Health Center | Onawa, IA | Hospital |
Floyd Valley Healthcare | Le mars, IA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cnos Pc | 4284548942 | 102 |
Cnos Pc | 4284548942 | 102 |
Cnos Pc | 4284548942 | 102 |
News Archive
The final results from an international clinical trial involving nearly 2,000 patients with Crohn's disease support the use of a new management strategy referred to as accelerated step-care as a best practice for the care of active Crohn's disease.
An international team of scientists has developed a water-soluble "warped nanographene", a flexible molecule that is biocompatible and shows promise for fluorescent cell imaging.
States that easily permit parents to opt out of vaccinating their children for nonmedical reasons are at increased risk of pertussis (whooping cough), according to a new study from researchers with the Johns Hopkins Bloomberg School of Public Health, the University of Florida and the Centers for Disease Control and Prevention (CDC).
On Monday, July 26th, U.S. Rep. Allyson Schwartz, Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), and Christopher Molineaux, president of Pennsylvania Bio, will host a roundtable discussion on the new Therapeutic Discovery Project Program. This new program offers small biotech companies (less than 250 employees) a tax credit or grant to encourage investment in new medical therapies for life-changing diseases.
› Verified 5 days ago
Entity Name | Cnos Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881604320 PECOS PAC ID: 4284548942 Enrollment ID: O20031217000907 |
News Archive
The final results from an international clinical trial involving nearly 2,000 patients with Crohn's disease support the use of a new management strategy referred to as accelerated step-care as a best practice for the care of active Crohn's disease.
An international team of scientists has developed a water-soluble "warped nanographene", a flexible molecule that is biocompatible and shows promise for fluorescent cell imaging.
States that easily permit parents to opt out of vaccinating their children for nonmedical reasons are at increased risk of pertussis (whooping cough), according to a new study from researchers with the Johns Hopkins Bloomberg School of Public Health, the University of Florida and the Centers for Disease Control and Prevention (CDC).
On Monday, July 26th, U.S. Rep. Allyson Schwartz, Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), and Christopher Molineaux, president of Pennsylvania Bio, will host a roundtable discussion on the new Therapeutic Discovery Project Program. This new program offers small biotech companies (less than 250 employees) a tax credit or grant to encourage investment in new medical therapies for life-changing diseases.
› Verified 5 days ago
Entity Name | Midlands Clinic Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649364894 PECOS PAC ID: 8820981681 Enrollment ID: O20040205000255 |
News Archive
The final results from an international clinical trial involving nearly 2,000 patients with Crohn's disease support the use of a new management strategy referred to as accelerated step-care as a best practice for the care of active Crohn's disease.
An international team of scientists has developed a water-soluble "warped nanographene", a flexible molecule that is biocompatible and shows promise for fluorescent cell imaging.
States that easily permit parents to opt out of vaccinating their children for nonmedical reasons are at increased risk of pertussis (whooping cough), according to a new study from researchers with the Johns Hopkins Bloomberg School of Public Health, the University of Florida and the Centers for Disease Control and Prevention (CDC).
On Monday, July 26th, U.S. Rep. Allyson Schwartz, Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), and Christopher Molineaux, president of Pennsylvania Bio, will host a roundtable discussion on the new Therapeutic Discovery Project Program. This new program offers small biotech companies (less than 250 employees) a tax credit or grant to encourage investment in new medical therapies for life-changing diseases.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Sarah Bligh, MD 2730 Pierce St, Ste. 402, Sioux City, IA 51104-3796 Ph: (712) 234-8725 | Sarah Bligh, MD 705 N Sioux Point Rd Ste 100, Dakota Dunes, SD 57049-5091 Ph: (605) 217-5500 |
News Archive
The final results from an international clinical trial involving nearly 2,000 patients with Crohn's disease support the use of a new management strategy referred to as accelerated step-care as a best practice for the care of active Crohn's disease.
An international team of scientists has developed a water-soluble "warped nanographene", a flexible molecule that is biocompatible and shows promise for fluorescent cell imaging.
States that easily permit parents to opt out of vaccinating their children for nonmedical reasons are at increased risk of pertussis (whooping cough), according to a new study from researchers with the Johns Hopkins Bloomberg School of Public Health, the University of Florida and the Centers for Disease Control and Prevention (CDC).
On Monday, July 26th, U.S. Rep. Allyson Schwartz, Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), and Christopher Molineaux, president of Pennsylvania Bio, will host a roundtable discussion on the new Therapeutic Discovery Project Program. This new program offers small biotech companies (less than 250 employees) a tax credit or grant to encourage investment in new medical therapies for life-changing diseases.
› Verified 5 days ago
William R Blankenship, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 705 Sioux Point Rd, Suite 100, Dakota Dunes, SD 57049 Phone: 605-217-5500 Fax: 605-217-5515 | |
Dr. Alexander M. Sarkisian, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 575 N Sioux Point Rd, Dakota Dunes, SD 57049 Phone: 605-217-2667 Fax: 605-217-2900 | |
Michael V Persaud, DO Gastroenterology Medicare: Medicare Enrolled Practice Location: 101 Tower Rd, Suite 105, Dakota Dunes, SD 57049 Phone: 712-255-1414 | |
Dr. Dustin S Sorenson, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 600 N Sioux Point Rd, Dakota Dunes, SD 57049 Phone: 605-232-3332 | |
Dr. Kelly L Delaney-nelson, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 575 N Sioux Point Rd, Dakota Dunes, SD 57049 Phone: 605-217-2667 | |
Dr. Kevin L. Preston, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 101 Tower Road, Suite 100, Dakota Dunes, SD 57049 Phone: 605-217-4310 Fax: 605-217-2915 |